… effective for COVID-19, and larger–sample size clinical trials of FNC for treating COVID-19
are … Recently, NMPA conditionally approved FNC to treat common COVID-19 in adults on 25 …

… treatments. Based on these premises, this review aims to discuss the most updated
pharmacological treatments to … to any current and future developments in curing COVID-19 …

… of favipiravir for COVID-19 is summarized. Additionally, some light is thrown on the treatment
recommendations pertaining to its inclusion in treating COVID-19 and the approval status in …

… hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform
trial … of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with …

… hospitalized adults with laboratory-confirmed Covid-19, we designed an adaptive platform
trial … of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with …

… place in China for the treatment of moderate to severe COVID-19, with recruitment terminated
… of COVID-19 patients, remdesivir may offer an effective and viable future treatment option. …

… present with similar complications (eg, ARDS, lung failure, and multiple organ dysfunction),
MSC-based therapy has potential as a treatment strategy against COVID-19. …

… We wanted to know if remdesivir is an effective treatment for people in hospital with COVID‐19
… of the success of remdesivir in treating COVID‐19. Types of breathing support included: …

… drug regimen for COVID-19 currently exists. Drug … treating this disease. Here, we have
highlighted a few available antimicrobial agents that could be very effective in treating COVID-19; …

… of patients with COVID-19 provide valuable information with … treatment regimens. This
review provides an updated overview of the main pathological changes observed in COVID-19 …